EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC 4.0

TriageHF ® in Real-World Practice: The Limits of “No News Is Good News”

Masataka Kawana iD

International Journal of Heart Failure · 2026 · 8 (3) · 263

DOI: 10.36628/ijhf.2026.0083 ↗

Kurz gefasst

Editorial in der Zeitschrift International Journal of Heart Failure, 2026. Verfasst von Masataka Kawana. Beteiligte Einrichtung: Advanced Heart Failure and Transplant Cardiology, Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine…. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) remains one of the most resource-intensive conditions in cardiovascular medicine, and ambulatory monitoring has moved rapidly from single-parameter surveillance (weight, symptom diaries, thoracic impedance) toward multiparametric, sensor-fused algorithms.Multisensor algorithms embedded in cardiac implantable electronic devices (CIEDs) have shown promise across retrospective and prospective cohorts for anticipating decompensation before it reaches the emergency department, 1,2) reflecting a simple logic: HF hospitalizations are common, costly, and often preventable if risk is identified early.A large proportion of HF patients already carry CIEDs-implantable defibrillators, permanent pacemakers, and resynchronization devices-that continuously capture diagnostic data repurposable for HF risk stratification at no additional cost or procedure.This is the appeal of algorithms such as TriageHF ® (Medtronic, Minneapolis, MN, USA), which combines intrathoracic impedance, activity level, nocturnal heart rate, heart rate variability, atrial fibrillation burden, percentage of resynchronization pacing, and detection of ventricular arrhythmias into a daily estimate of 30-day HF event risk. 1) Because the hardware is already implanted, CIED-based risk scores are among the most immediately scalable remote monitoring tools available today.In this issue of the journal, Pereira Santos et al. 3) reported a real-world, modestly sized, retrospective cohort study evaluating the performance of TriageHF ® .Their cohort had an event rate of 7.9% per month during high-risk alert days, compared with 0.8% per month during standard-risk days; TriageHF ® yielded a sensitivity of 35%, a specificity of 71%, a positive predictive value (PPV) of 25%, and a negative predictive value (NPV) of 80% for predicting a composite of HF hospitalization and unplanned emergency room visits.Notably, rather than using the maximal monthly risk score employed in other studies, they defined high-risk exposure by the cumulative duration of continuous days under a high-risk alert.This is a coarser unit of analysis: with fewer independent observations per patient than a day-or month-level analysis provides, the resulting estimates carry more statistical noise, and they answer a different question-the probability that a patient who ever crosses the high-risk threshold ever has an event during follow-up, rather than the probability that a specific high-risk day or month is followed by an event within a defined window.The two are not directly interchangeable, and this difference in granularity should be kept in mind when comparing this cohort's figures with the day-or evaluation-level estimates below.Even with that caveat, the low sensitivity and PPV reflect a pattern that sits within the wide range of algorithm performance established by prior work.The original report by Cowie et al. 1) that developed TriageHF ® showed a high-risk PPV of 6.8%

Autor:innen und Institutionen

  • Advanced Heart Failure and Transplant Cardiology, Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

ORCID-Profile: Masataka Kawana

Zitieren

APA

Kawana, M. (2026). TriageHF ® in Real-World Practice: The Limits of “No News Is Good News”. International Journal of Heart Failure, 8(3), 263. https://doi.org/10.36628/ijhf.2026.0083

Vancouver

Kawana M. TriageHF ® in Real-World Practice: The Limits of “No News Is Good News”. International Journal of Heart Failure. 2026;8(3):263. doi:10.36628/ijhf.2026.0083

BibTeX
@article{Kawana2026,
  author = {Kawana, Masataka},
  title = {TriageHF ® in Real-World Practice: The Limits of “No News Is Good News”},
  journal = {International Journal of Heart Failure},
  year = {2026},
  volume = {8},
  number = {3},
  pages = {263},
  doi = {10.36628/ijhf.2026.0083}
}
Kostenlos starten →